世卫将获近20亿剂疫苗
Global vaccine supply increases
世界卫生组织12月18日宣布，已与多个疫苗研发或生产机构就疫苗采购事宜签署协议或意向声明，保证世卫组织主导的COVAX全球新冠疫苗计划将能获得近20亿剂新冠疫苗，这些疫苗最快将从明年一季度起提供给参与计划的各经济体。
The WHO announced that COVAX has agreements in place to access nearly 2 billion doses of several promising vaccine candidates on Friday, and first deliveries are anticipated to begin in the first quarter of 2021.
COVAX明年将向92个符合条件的中低收入经济体提供13亿剂获批疫苗。
The initiative said it aims to deliver 1.3 billion doses of approved vaccines next year to 92 eligible low- and middle-income economies.
COVAX在一份声明中表示，所有190个签署了COVAX协议的经济体“将在2021年上半年获得疫苗，根据监管机构的批准和各国准备就绪情况，预计2021年第一季度开始交付首批疫苗。”
All 190 economies that have signed up to COVAX will "have access to doses in the first half of 2021, with first deliveries anticipated to begin in the first quarter of 2021 – contingent upon regulatory approvals and countries' readiness for delivery," it said in a statement.
12月18日宣布的新协议包括与阿斯利康签订的1.7亿剂疫苗预购协议，以及与强生签署的5亿剂疫苗谅解备忘录。
New agreements announced on Friday include an advance purchase agreement with AstraZeneca for 170 million doses, and a memorandum of understanding for 500 million doses from Johnson and Johnson.